Page last updated: 2024-11-07

spironolactone and Day Blindness

spironolactone has been researched along with Day Blindness in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben Salem, S1
Sithom, A1
Ben Dhia, I1
Khelifi, T1
Askri, H1
Ayed, A1
Watillon, M1
Robe-Vanwyck, A1

Other Studies

2 other studies available for spironolactone and Day Blindness

ArticleYear
Central serous chorioretinopathy after nasal corticosteroids in the aviator.
    La Tunisie medicale, 2016, Volume: 94, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Central Serous Chorioretinopathy; Fluorescein Angiography; Humans; M

2016
[Harmful effects of common drugs on the visual apparatus. Diuretics].
    Bulletin de la Societe belge d'ophtalmologie, 1972, Volume: 160, Issue:1

    Topics: Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Diuretics; Drug Synergism; Eye Diseases; Hum

1972